TearClear
PrivateLast Round
Series C
Jun 28, 2023
Total Funding Raised
$51.95M
Company Overview
TearClear is a life sciences company that develops ophthalmic drugs intended to transform trusted ophthalmic medications into preservative-free therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TearClear Comparables
Compare TearClear with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laboratoires Théa | 74% | |
| Novartis | 72% | |
| Nemera | 71% | |
TearClear Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 28, 2023 | ||||
| Debt | Aug 2, 2022 | ||||
| Series B | Aug 11, 2020 | ||||
| Debt | Jan 31, 2020 | ||||
| Series A Extension | Feb 1, 2019 | ||||
Series A | May 30, 2017 |
Key People
Founding team and executive leadership
TearClear Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kohlberg Kravis Roberts | Series B |
| Flying L Partners | Series B |
| Falcon Vision | Series B |
| KKR | Series B |
| Visionary Ventures | Series B, Series A Extension, Series A |
| Bluestem Capital | Series B, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2017
$4.5M round led by Bluestem Capital and Visionary Ventures.
TearClear Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TearClear's valuation, stock price, and market status.